dactinomycin has been researched along with Hepatitis C, Chronic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujikawa, K; Ito, T; Nakano, T; Ohmori, S; Okano, H; Sakai, T; Shiraki, K; Sugimoto, K; Takase, K; Wagayama, H; Yamanaka, T | 1 |
1 other study(ies) available for dactinomycin and Hepatitis C, Chronic
Article | Year |
---|---|
CD40 expression in HCV-associated chronic liver diseases.
Topics: Antibodies, Monoclonal; Apoptosis; CD40 Antigens; Cell Line, Tumor; Cell Survival; Dactinomycin; Hepacivirus; Hepatitis C, Chronic; Hepatocytes; Humans; Immunohistochemistry; Liver Diseases; Luciferases; NF-kappa B; Protein Synthesis Inhibitors; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Transfection | 2006 |